Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Photocatalytic construction of N-acyl-N,O-acetal-linked pyridines via aminocyclopropane ring opening

Doyoung Kimab, Eunseon Yangab, Yoonhee Choab and Sungwoo Hong*ab
aDepartment of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Korea. E-mail: hongorg@kaist.ac.kr
bCenter for Catalytic Hydrocarbon Functionalizations, Institute for Basic Science (IBS), Daejeon 34141, Korea

Received 18th October 2025 , Accepted 8th December 2025

First published on 9th December 2025


Abstract

Pyridine and quinoline linkers are privileged motifs in medicinal chemistry, yet their site-selective installation into complex scaffolds remains challenging. Here, we report that aminocyclopropanes serve as precursors to N-acyl-N,O-acetal linkers installed onto pyridines via visible-light-driven ring opening under oxidant-free conditions. The ring-opened radical is captured by N-aminopyridinium salts to forge C(sp3)–C(aryl) bonds at the C4-selective site of the pyridine core, while the concomitantly released N-centered radical oxidizes the reduced photocatalyst, enabling efficient turnover. Subsequent nucleophile trapping furnishes N-acyl-N,O-acetals bearing pyridine or quinoline units with a broad scope across both heteroarenes and aminocyclopropanes, including late-stage diversification of complex molecules. Substituting methanol with TMSN3 provides azido-aminals, further expanding accessible architectures. The resulting N-acyl-N,O-acetal moieties function as versatile linchpins that engage diverse downstream manifolds, thereby enabling modular assembly and late-stage diversification of pyridine-containing targets.


Introduction

Pyridine and quinoline are among the most ubiquitous heteroarenes in pharmaceuticals, agrochemicals, ligands, and functional materials, reflecting their exceptional versatility and frequent occurrence in clinical candidates and approved drugs (Fig. 1a).1 Their tunable basicity, metabolic stability, and well-defined hydrogen-bond-accepting characteristics make them particularly attractive for pharmaceutical design, in which the incorporation of pyridine enables the introduction of solubilizing groups, photoaffinity tags, and heterobifunctional tethers with tailored functional properties.2
image file: d5sc08055j-f1.tif
Fig. 1 Photocatalytic construction of pyridyl-linked N-acyl-N,O-acetals via aminocyclopropane ring opening promoted by PC/amidyl radicals.

In parallel, N-acyl-N,O-acetals (and their hemiaminal congeners), which are frequently encountered as key motifs in bioactive and pharmaceutical molecules,3 represent bench-stable and readily diversifiable scaffolds that are attracting increasing attention.4 Nucleophile-induced substitution at the acetal carbon, acetal exchange, and controlled hydrolysis, oxidation, or reductive amination provide rapid entry to families of medicinally relevant building blocks. Owing to their facile activation under both Brønsted-acidic and metal-catalyzed conditions, these motifs function as reliable linchpins for fragment coupling, rearrangement, and heterofunctionalization.5 However, general and site-selective strategies that enable the direct installation of N,O-acetal linkers under mild conditions, and particularly those that can install them at the C4 position of pyridines and the corresponding site in quinolines, remain scarce. The C4 position offers an orthogonal exit vector from the pyridyl core, enabling bond formation in a distinct spatial direction and providing a well-defined platform for constructing bifunctional linkers, photoaffinity tags, and PROTAC-type heterobifunctional tethers.

Cyclopropanes have emerged as C3 synthons that combine operational stability with latent reactivity unmasked by ring opening.6 While the Lewis-acid and transition-metal activation of suitably polarized cyclopropanes is well established,7 substrates lacking strong electronic bias, such as cyclopropanes bearing only a single donor or single acceptor group, as well as arylcyclopropanes, often remain recalcitrant. Recently, photochemistry-driven single-electron transfer (SET) has emerged as a powerful strategy to achieve these demanding conversions.8 It has proven particularly effective in delivering ring-opening functionalizations under mild conditions.9 Among the cyclopropanes, aminocyclopropanes are particularly attractive: SET oxidation generates an amidyl radical that undergoes β-scission to give a distonic iminium radical primed for further functionalization.10 Despite advances in the radical chemistry of aminocyclopropanes, direct, C4-selective heteroarylation that can achieve both pyridyl- and quinolyl-linked N,O-acetal (or hemiaminal) frameworks has remained underexplored. The integration of C4-selective heteroaryl functionalization with concurrent N,O-acetal (or hemiaminal) formation would thus provide a powerful and modular platform for the synthesis of functional molecules and for late-stage diversification.

N-Aminopyridinium salts have recently emerged as versatile pyridine electrophiles that undergo radical coupling under mild, site-selective conditions.11 A key advantage is that N–N bond fragmentation releases a sulfonamidyl fragment that can act as an internal terminal oxidant, obviating external oxidants and enabling closed catalytic cycles.12 We reasoned that these attributes would permit efficient capture of ring-opened γ-radicals derived from aminocyclopropanes, forging C(sp3)–C(aryl) bonds with an intrinsic preference for addition at the pyridyl C4 site (and the corresponding quinoline position), thereby appending a functionalized linker in a single step. Here, we report a visible-light-driven coupling of aminocyclopropanes with N-aminopyridinium salts that directly installs N-acyl-N,O-acetal (hemiaminal) scaffolds into the pyridine or quinoline under neutral, oxidant-free conditions (Fig. 1b). The transformation displays broad functional-group tolerance across both heteroarenes and aminocyclopropanes, is operationally simple, and delivers excellent C4 regioselectivity via a SET-initiated β-scission/addition/rearomatization sequence.11d,f Crucially, the resulting N-acyl-N,O-acetals serve as versatile synthetic linchpins that can engage diverse functionalization manifolds. The intact scaffold undergoes a variety of nucleophilic substitution reactions at the acetal carbon with organometallic reagents, indoles, thiols, cyanide, and phosphines, as well as Mukaiyama and Petasis-type reactions, underscoring its versatility for further functionalization. This strategy opens the way to structurally diverse pyridine-containing motifs that were previously difficult to obtain, broadening the accessible chemical space for pyridyl derivatives. It provides a modular late-stage route to 4-pyridyl-linked architectures, transforming aminocyclopropanes into general precursors that enable both structural remodeling and functional diversification.

Results and discussion

To evaluate the feasibility of our design, we examined the model coupling between N-cyclopropyl-4-methoxybenzamide (1a) and N-aminopyridinium salt 2 in MeCN using the 3,6-di-tert-butyl-9-mesityl-10-phenylacridinium tetrafluoroborate as a photocatalyst (PC) and MeOH under blue-LED irradiation (Table 1). The initial reaction afforded the ring-opened γ-pyridyl N,O-acetal 3a in 65% yield with exclusive C4-selectivity (entry 1). Systematic variation of the reaction parameters identified temperature control as the key factor influencing performance; implementation of precise thermal regulation significantly improved consistency. Further thermal profiling revealed that mild cooling enhanced the yield, whereas heating led to diminished efficiency (entries 2 and 3). At −20 °C, the reaction rate decreased; however, prolonged irradiation at this temperature afforded 3a in 81% yield (entries 4 and 5). Screening of various photocatalysts confirmed that the original acridinium photocatalyst was optimal (entries 6–9, Ered = +2.08 V, 1.21 V, 0.66 V, 1.35 V vs. SCE, respectively),13 consistent with the need for a strong photooxidant to engage 1a. Examination of the aryl substituent on the pyridinium electrophile showed that both unsubstituted and CF3-substituted aryl groups maintained high C4-selectivity, with only a modest reduction in reactivity in the latter case (entries 10 and 11). In contrast, protonated or N–O-substituted salts (2d and 2e) exhibited reduced efficiency and diminished selectivity due to formation of the C2-substituted product, consistent with prior reports11j (entries 12 and 13).
Table 1 Optimization of the reaction conditionsa

image file: d5sc08055j-u1.tif

Entry PC Salt Temp. Yield
a Reaction conditions: 1a (0.05 mmol), 2 (1.5 equiv.), PC (2.5 mol%), MeOH (3.0 equiv.) in MeCN (0.5 mL) under irradiation with 440 nm LEDs (10 W) at 25 °C for 18 h under argon. Yields determined by 1H NMR spectroscopy using caffeine as an internal standard. Isolated yield and regioisomeric ratio (C4 vs. C2) are given in parentheses. PMP = p-methoxy phenyl.b Reaction time: 40 h.c 1 mol% of PC used.
1 [tBu2-Mes-Ph-Acr]BF4 2a 25 °C 65%
2 [tBu2-Mes-Ph-Acr]BF4 2a 40 °C 58%
3 [tBu2-Mes-Ph-Acr]BF4 2a 10 °C 68%
4 [tBu2-Mes-Ph-Acr]BF4 2a −20 °C 34%
5 [tBu2-Mes-Ph-Acr]BF4 2a −20 °C 81%b (80%)
6 [Mes-Acr]BF4 2a −20 °C 69%b
7 [Ir{dF(CF3)ppy}2dtbbpy]PF6 2a −20 °C 48%b,c
8 [Ir(ppy)2dtbbpy]PF6 2a −20 °C 11%b,c
9 4CzIPN 2a −20 °C 30%b
10 [tBu2-Mes-Ph-Acr]BF4 2b −20 °C 78%b
11 [tBu2-Mes-Ph-Acr]BF4 2c −20 °C 68%b
12 [tBu2-Mes-Ph-Acr]BF4 2d −20 °C 41%b (1[thin space (1/6-em)]:[thin space (1/6-em)]1)
13 [tBu2-Mes-Ph-Acr]BF4 2e −20 °C 31%b (1.4[thin space (1/6-em)]:[thin space (1/6-em)]1)


With the optimized conditions in hand, we investigated the scope of the reaction to determine its generality and late-stage utility (Tables 2 and 3). Substitution at C2 of the pyridinium electrophile was broadly tolerated across electronic regimes, furnishing good yields for both electron-donating and electron-withdrawing groups (3a–3c). Phenyl-ring substitution proved productive, with methoxy- and trifluoromethyl-substituted 3d and 3e delivering high yields and bipyridyl-substituted 3f remaining competent. C3-substituted salts, including halide and ester variants, reacted smoothly (3g–3i). Likewise, disubstituted pyridines underwent the transformation with comparable efficiency (3j–3l). Notably, a fused-ring substrate afforded the desired product 3m in excellent yield, and unsubstituted pyridine underwent smooth conversion (3n). The platform was extended to quinolines bearing C2 or C6 substituents (3o, 3p), indicating its translatability across azine scaffolds. To demonstrate its utility in late-stage derivatization, derivatives of vismodegib, bisacodyl, clofibric acid, and valproic acid were functionalized in good efficiency with C4 selectivity throughout (3q–3t).

Table 2 Scope of pyridyl ringsa
a Reaction conditions: 1a (0.1 mmol), 2 (0.15 mmol), tBu2-Mes-Ph-Acr (2.5 mol%), MeOH (0.3 mmol) in MeCN (1.0 mL) under irradiation with 440 nm LEDs (10 W) at −20 °C for 40 h under argon.
image file: d5sc08055j-u2.tif


Table 3 Scope of aminocyclopropanes and extension to azide nucleophilesa
a Reaction conditions: 1 (0.1 mmol), 2a (0.15 mmol), tBu2-Mes-Ph-Acr (2.5 mol%), MeOH (0.3 mmol) in MeCN (1.0 mL) under irradiation with 440 nm LEDs (10 W) at −20 °C for 40 h under an argon atmosphere. Azidation: TMSN3 (0.3 mmol) was used instead of MeOH.b Reaction at room temperature.c 24 h reaction time.d 72 h reaction time.e Reaction at room temperature, 24 h reaction time, 5 mol% of PC used.f 5 equiv. of MeOH and 2b used.g Yield of inseparable diastereomer mixtures.h H2O instead of MeOH. Diastereomeric ratios determined by 1H NMR analysis of the crude mixtures.
image file: d5sc08055j-u3.tif


Turning to the aminocyclopropane partner (Table 3, top), an aryl-substituted cyclopropane delivered product 4a. Para-substituted arenes bearing electron-donating or electron-withdrawing groups were compatible (4b, 4c–4f), and meta/ortho substitution patterns were likewise tolerated with comparable efficiencies (4g–4j). Extended aromatics such as naphthalene and benzothiophene performed well (4k, 4l). Increasing the ring-size from cyclopropyl to cyclobutyl was viable (4m). Aliphatic and benzylic variants were accommodated (4n–4p), as were ether-containing substrates (4q), and common N-protecting groups (Cbz and Troc) were retained (4r, 4s).

To expand the versatility of the reaction, we tried changing the substituents. The reaction was also successfully carried out in the case of 1,2-disubstituted and difluorine-substituted aminocyclopropane (4t, 4u). Notably, the desired products were secured even from the tertiary amide substrate (4v), which was previously reported to be unreactive or susceptible to decomposition owing to product instability.10b–d,10f Also, substituting water for methanol as the nucleophile furnished the corresponding product under the standard conditions (4w). Finally, late-stage diversification of pharmaceutically relevant scaffolds (isoxepac, oxaprozin, probenecid) proceeded in synthetically useful yields (4x–4z). Collectively, these scope examinations highlight the broad compatibility of this reaction across electronic properties, substitution patterns, and molecular complexity, enabling late-stage diversification while preserving C4 selectivity.

To expand the nucleophile scope, we explored the use of TMSN3 as an azide source (Table 3, bottom). Under the optimized photoredox conditions, a variety of pyridinium salts and aminocyclopropanes were smoothly converted into the corresponding azido aminals. Within the pyridinium series, both a C2-substituted pyridine (5a) and a C2-substituted quinoline (5b) furnished the desired products in high yields. Electron-rich and extended aromatic aminocyclopropanes were also competent partners: the o-methoxy benzamide derivative (5c) and the naphthamide analogue (5d) delivered the products efficiently. Furthermore, late-stage azidation of drug-derived substrates such as pyriproxyfen (5e), bisacodyl (5f), and the bioactive scaffold isoxepac (5g) proceeded in synthetically useful yields.

To elucidate the reaction pathway, we performed a series of control and trapping experiments. Excluding either the photocatalyst or light completely suppressed product formation, and the reaction proved sensitive to air (Table S6 in the SI), ruling out a two-electron mechanism. Radical inhibition by TEMPO halted the reaction, while butylated hydroxytoluene and 1,1-diphenylethylene significantly reduced conversion; the TEMPO adduct was detected by LC-MS, confirming radical intermediacy (Table S7 in the SI). Evidence for an N-centered radical was obtained using linear pentyl benzamide: under standard conditions, 7 underwent H-atom transfer to give 8, consistent with amidyl generation (Fig. 2a, top).14 The formation of product 4v from a tertiary amide lacking an N–H bond demonstrates that the reaction proceeds without N–H abstraction by the N-methyl-tosyl radical, thereby supporting a SET-based pathway. In addition, employing Ir(ppy)3, which is insufficiently oxidizing to activate the aminocyclopropane, led to only trace product formation. Likewise, the use of a base to promote an electron–donor–acceptor complex resulted in no reaction (Fig. 2a, bottom). Taken together, these data indicate that H-abstraction from the amide by the N-methyl-tosyl radical is unlikely to be a productive pathway. Finally, the low quantum yield (Φ = 0.145) further indicates that any chain-propagation pathway is minimal (see SI). Stern–Volmer quenching confirmed that 1a efficiently quenches the excited photocatalyst, supporting initial SET oxidation of the aminocyclopropane (Fig. 2b). On the basis of these results and precedents, we propose the mechanism shown in Fig. 2c. Photoexcited acridinium (Ered = +2.15 V vs. SCE)13 oxidizes the aminocyclopropane (Ep = +1.67 V vs. SCE);10c subsequent β-scission yields a distonic iminium radical cation (Int-1). Coupling with the N-aminopyridinium electrophile forms the pyridylated iminium ion (Int-2) with concurrent N–N bond cleavage to release an N-methyl-tosyl radical (Ered,cal = +0.47 V vs. SCE in MeCN),12b which closes the catalytic cycle via oxidation of the reduced photocatalyst (Eox = −0.52 V vs. SCE).13 Trapping of the iminium by the nucleophile (MeOH or TMSN3) affords the observed N,O-acetal or azido aminal products.


image file: d5sc08055j-f2.tif
Fig. 2 Mechanistic studies and synthetic utility. aFrom 5a.

Gram-scale reactions (5 mmol N,O-acetal, 3 mmol azido aminal) delivered the products in 61% and 65% yield, respectively (Table S8 in the SI), demonstrating the scalability and practicality of this approach. The resulting scaffolds underwent diverse downstream transformations (Fig. 2d): Grignard and organozinc additions furnished alkynylated and alkylated derivatives (6a, 6b); Lewis-acid activation enabled cyanation, phosphorylation, and indole C3-alkylation (6c–6e). Mukaiyama and Petasis-type reactions with silyl enol ethers or tetrafluoroborate salts provided ester, aldehyde, and alkene motifs (6f–6h). TFA-mediated thiol additions generated stable N,S-acetal (6i) and allowed peptide-based thiol to be incorporated (6j), demonstrating compatibility with biomolecular substrates. Finally, the reduction of azido aminal product 5a yielded the corresponding amine, which was readily protected as Boc derivative 6k. Overall, these mechanistic and synthetic studies underscore both the radical nature and the broad synthetic versatility of this transformation, establishing it as a robust platform for the late-stage diversification of pyridine-linked scaffolds.

Conclusions

This work establishes a broadly applicable platform for the installation of N-acyl-N,O-acetal moieties onto pyridine and quinoline via visible-light activation of aminocyclopropanes. By converting strain release into selective C(sp3)–C(aryl) bond formation, this method enables the mild, oxidant-free installation of N-acyl-N,O-acetals linkers into pyridines, delivering excellent C4-regioselectivity and broad substrate scope. The transformation integrates radical reactivity with programmable functionalization, thus offering a general approach for late-stage diversification and modular assembly of heteroaromatic frameworks. Beyond providing a practical tool for medicinal chemistry, this strategy redefines aminocyclopropanes as versatile precursors for the installation of N-acyl-N,O-acetals and incorporation of diverse nucleophiles, enabling modular access to heteroaryl frameworks bearing tunable functionalities.

Author contributions

D. K. and S. H. conceived the idea of the project. D. K., E. Y. and Y. C. performed the experiments and analyzed the data. All authors wrote the manuscript.

Conflicts of interest

There are no conflicts to declare.

Data availability

Detailed synthetic procedures, supporting experimental results, and complete characterization data for all new compounds can be found in the supplementary information (SI). Supplementary information: experimental procedure, characterization of new compounds (1H and 13C NMR spectra). See DOI: https://doi.org/10.1039/d5sc08055j.

Acknowledgements

This research was supported financially by Institute for Basic Science (IBS-R010-A2).

Notes and references

  1. (a) S. De, A. Kumar S K, S. K. Shah, S. Kazi, N. Sarkar, S. Banerjee and S. Dey, RSC Adv., 2022, 12, 15385–15406 Search PubMed; (b) A. R. Dwivedi, S. Jaiswal, D. Kukkar, R. Kumar, T. G. Singh, M. P. Singh, A. M. Gaidhane, S. Lakhanpal, K. N. Prasad and B. Kumar, RSC Med. Chem., 2024, 16, 12–36 Search PubMed.
  2. (a) E. Karaj, S. H. Sindi and L. M. Viranga Tillekeratne, Bioorg. Med. Chem., 2022, 62, 116721 Search PubMed; (b) M. B. Islam, M. I. Islam, N. Nath, T. B. Emran, M. R. Rahman, R. Sharma and M. M. Matin, Biomed Res. Int., 2023, 2023, 9967591 Search PubMed; (c) R. P. Wurz, H. Rui, K. Dellamaggiore, S. Ghimire-Rijal, K. Choi, K. Smither, A. Amegadzie, N. Chen, X. Li, A. Banerjee, Q. Chen, D. Mohl and A. Vaish, Nat. Commun., 2023, 14, 4177 Search PubMed; (d) Z. He, W. Yang, F. Yang, J. Zhang and L. Ma, Eur. J. Med. Chem., 2024, 279, 116842 Search PubMed; (e) Y. Dong, T. Ma, T. Xu, Z. Feng, Y. Li, L. Song, X. Yao, C. R. Ashby Jr and G.-F. Hao, Acta Pharm. Sin. B, 2024, 14, 4266–4295 Search PubMed.
  3. R. A. Mosey and P. E. Floreancig, Nat. Prod. Rep., 2012, 29, 980–995 Search PubMed.
  4. (a) Y. Harayama, M. Yoshida, D. Kamimura and Y. Kita, Chem. Commun., 2005, 1764–1766 Search PubMed; (b) M. Li, B. Luo, Q. Liu, Y. Hu, A. Ganesan, P. Huang and S. Wen, Org. Lett., 2014, 16, 10–13 Search PubMed; (c) L. Dian, S. Wang, D. Zhang-Negrerie, Y. Du and K. Zhao, Chem. Commun., 2014, 50, 11738–11741 Search PubMed; (d) M. Gasonoo, Z. W. Thom and S. Laulhé, J. Org. Chem., 2019, 84, 8710–8716 Search PubMed; (e) X.-J. Lv, Y.-C. Ming, H.-C. Wu and Y.-K. Liu, Org. Chem. Front., 2021, 8, 6309–6316 Search PubMed; (f) C. Sheng, Z. Ling, Y. Luo and W. Zhang, Nat. Commun., 2022, 13, 400 Search PubMed; (g) X.-Y. Ma, F.-Q. Shao, X. Hu and X. Liu, Synthesis, 2022, 54, 1203–1216 Search PubMed; (h) M. A. Ganie, F. Fayaz, M.-U.-S. Bhat, M. A. Rizvi, S. Raheem and B. A. Shah, Org. Lett., 2023, 25, 8234–8239 Search PubMed; (i) D. Steuernagel, D. Rombach and H.-A. Wagenknecht, Chem.–Eur. J., 2024, 30, e202400247 Search PubMed; (j) A. Lin, A. Ghosh, S. Yellen, Z. T. Ball and L. Kürti, J. Am. Chem. Soc., 2024, 146, 21129–21136 Search PubMed.
  5. (a) E. H. Cordes and H. G. Bull, Chem. Rev., 1974, 74, 581–603 Search PubMed; (b) M. Hamon, N. Dickinson, A. Devineau, D. Bolien, M.-J. Tranchant, C. Taillier, I. Jabin, D. C. Harrowven, R. J. Whitby, A. Ganesan and V. Dalla, J. Org. Chem., 2014, 79, 1900–1912 Search PubMed; (c) A. H. Cherney, N. T. Kadunce and S. E. Reisman, Chem. Rev., 2015, 115, 9587–9652 Search PubMed; (d) Y. You, Q. Van Pham and S. Ge, CCS Chem., 2019, 1, 455–463 Search PubMed; (e) A. M. Borys, J. M. Gil-Negrete and E. Hevia, Chem. Commun., 2021, 57, 8905–8908 Search PubMed; (f) Y. Chun, K. B. Luu and K. A. Woerpel, Synlett, 2024, 35, 1763–1787 Search PubMed; (g) K. B. Luu, A. Ramdular, E. Finkelstein, A. G. Shtukenberg and K. A. Woerpel, Org. Lett., 2024, 26, 10470–10474 Search PubMed.
  6. (a) H. N. C. Wong, M. Y. Hon, C. W. Tse, Y. C. Yip, J. Tanko and T. Hudlicky, Chem. Rev., 1989, 89, 165–198 Search PubMed; (b) H.-U. Reissig and R. Zimmer, Chem. Rev., 2003, 103, 1151–1196 Search PubMed; (c) C. Ebner and E. M. Carreira, Chem. Rev., 2017, 117, 11651–11679 Search PubMed.
  7. (a) T. F. Schneider, J. Kaschel and D. B. Werz, Angew. Chem., Int. Ed., 2014, 53, 5504–5523 Search PubMed; (b) M. A. Cavitt, L. H. Phun and S. France, Chem. Soc. Rev., 2014, 43, 804–818 Search PubMed; (c) H. K. Grover, M. R. Emmett and M. A. Kerr, Org. Biomol. Chem., 2015, 13, 655–671 Search PubMed; (d) E. Budynina, K. Ivanov, I. Sorokin and M. Melnikov, Synthesis, 2017, 49, 3035–3068 Search PubMed; (e) G. Fumagalli, S. Stanton and J. F. Bower, Chem. Rev., 2017, 117, 9404–9432 Search PubMed; (f) K. Ghosh and S. Das, Org. Biomol. Chem., 2021, 19, 965–982 Search PubMed; (g) T. Feng, C. Liu, Z. Wu, X. Wu and C. Zhu, Chem. Sci., 2022, 13, 2669–2673 Search PubMed; (h) A. Ratzenböck, M. Kobras, A. Rustler and O. Reiser, Chem.–Eur. J., 2024, 30, e202401332 Search PubMed; (i) A. S. Adhikari and N. Majumdar, Eur. J. Org Chem., 2024, 27, e202301225 Search PubMed.
  8. (a) X. Zhang and D. W. C. MacMillan, J. Am. Chem. Soc., 2017, 139, 11353–11356 Search PubMed; (b) Y. Liang, X. Zhang and D. W. C. MacMillan, Nature, 2018, 559, 83–88 Search PubMed; (c) J. Xu, J. Cao, X. Wu, H. Wang, X. Yang, X. Tang, R. W. Toh, R. Zhou, E. K. L. Yeow and J. Wu, J. Am. Chem. Soc., 2021, 143, 13266–13273 Search PubMed; (d) C. Hyeon Ka, S. Kim and E. Jin Cho, Chem. Rec., 2023, 23, e202300036 Search PubMed; (e) Q. Shi, X.-W. Kang, Z. Liu, P. Sakthivel, H. Aman, R. Chang, X. Yan, Y. Pang, S. Dai, B. Ding and J. Ye, J. Am. Chem. Soc., 2024, 146, 2748–2756 Search PubMed; (f) X. Tong, Z. Wu, H. T. Ang, Y. Miao, Y. Lu and J. Wu, ACS Catal., 2024, 14, 9283–9293 Search PubMed; (g) Y. Pang, E. Wang and J. Ye, Angew. Chem., Int. Ed., 2025, 64, e202508379 Search PubMed.
  9. (a) L. Ge, D.-X. Wang, R. Xing, D. Ma, P. J. Walsh and C. Feng, Nat. Commun., 2019, 10, 4367 Search PubMed; (b) M. Ji, Z. Wu and C. Zhu, Chem. Commun., 2019, 55, 2368–2371 Search PubMed; (c) H. Liu, Y. Li, D.-X. Wang, M.-M. Sun and C. Feng, Org. Lett., 2020, 22, 8681–8686 Search PubMed; (d) Q.-Q. Zhao, X.-S. Zhou, S.-H. Xu, Y.-L. Wu, W.-J. Xiao and J.-R. Chen, Org. Lett., 2020, 22, 2470–2475 Search PubMed; (e) Z. Zuo, C. G. Daniliuc and A. Studer, Angew. Chem., Int. Ed., 2021, 60, 25252–25257 Search PubMed; (f) M. Vellakkaran, T. Kim and S. Hong, Angew. Chem., Int. Ed., 2022, 61, e202113658 Search PubMed; (g) L. Ge, C. Zhang, C. Pan, D.-X. Wang, D.-Y. Liu, Z.-Q. Li, P. Shen, L. Tian and C. Feng, Nat. Commun., 2022, 13, 5938 Search PubMed; (h) T. V. T. Nguyen, M. D. Wodrich and J. Waser, Chem. Sci., 2022, 13, 12831–12839 Search PubMed; (i) D. Kim, H. Ju, W. Lee and S. Hong, Chem. Sci., 2024, 15, 20433–20439 Search PubMed; (j) W.-Y. Qu, X.-S. Zhou, W.-J. Xiao and J.-R. Chen, Sci. China Chem., 2024, 67, 3807–3816 Search PubMed; (k) J. Qi, C. Wang, G. Wang, P. O'Neill, S. Reddy Dubbaka, H. Ting Ang, X. Chen and J. Wu, Angew. Chem., Int. Ed., 2025, 64, e202413723 Search PubMed.
  10. (a) M.-M. Wang and J. Waser, Angew. Chem., Int. Ed., 2019, 58, 13880–13884 Search PubMed; (b) M.-M. Wang and J. Waser, Angew. Chem., Int. Ed., 2020, 59, 16420–16424 Search PubMed; (c) M.-M. Wang, T. V. T. Nguyen and J. Waser, J. Am. Chem. Soc., 2021, 143, 11969–11975 Search PubMed; (d) Z. Liu, S. Wu and Y. Chen, ACS Catal., 2021, 11, 10565–10573 Search PubMed; (e) P.-C. Xu, S. Qian, X. Meng, Y. Zheng and S. Huang, Org. Lett., 2024, 26, 2806–2810 Search PubMed; (f) H. Huang, X. Luan and Z. Zuo, Angew. Chem., Int. Ed., 2024, 63, e202401579 Search PubMed; (g) X. Dong, Y. Shao, Z. Liu, X. Huang, X.-S. Xue and Y. Chen, Angew. Chem., Int. Ed., 2024, 63, e202410297 Search PubMed.
  11. For selected examples: (a) T. W. Greulich, C. G. Daniliuc and A. Studer, Org. Lett., 2015, 17, 254–257 Search PubMed; (b) K. Miyazawa, T. Koike and M. Akita, Chemistry, 2015, 21, 11677–11680 Search PubMed; (c) W.-L. Yu, J.-Q. Chen, Y.-L. Wei, Z.-Y. Wang and P.-F. Xu, Chem. Commun., 2018, 54, 1948–1951 Search PubMed; (d) Y. Moon, B. Park, I. Kim, G. Kang, S. Shin, D. Kang, M.-H. Baik and S. Hong, Nat. Commun., 2019, 10, 4117 Search PubMed; (e) S. L. Rössler, B. J. Jelier, E. Magnier, G. Dagousset, E. M. Carreira and A. Togni, Angew. Chem., Int. Ed., 2020, 59, 9264–9280 Search PubMed; (f) W. Lee, S. Jung, M. Kim and S. Hong, J. Am. Chem. Soc., 2021, 143, 3003–3012 Search PubMed; (g) M. Kim, Y. Koo and S. Hong, Acc. Chem. Res., 2022, 55, 3043–3056 Search PubMed; (h) W. Choi, M. Kim, K. Lee, S. Park and S. Hong, Org. Lett., 2022, 24, 9452–9457 Search PubMed; (i) H. Cao, D. Kong, L. Yang, S. Chanmungkalakul, T. Liu, J. L. Piper, Z. Peng, L. Gao, X. Liu, X. Hong and J. Wu, Nat. Synth., 2022, 1, 794–803 Search PubMed; (j) L. Kim, W. Lee and S. Hong, Angew. Chem., Int. Ed., 2024, 63, e202410408 Search PubMed; (k) J. Kim, M. Kim, J. Jeong and S. Hong, J. Am. Chem. Soc., 2023, 145, 14510–14518 Search PubMed; (l) H. Ju, C.-Y. Tan and S. Hong, Synlett, 2025, 36, 1749–1752 Search PubMed.
  12. (a) H. Choi, G. R. Mathi, S. Hong and S. Hong, Nat. Commun., 2022, 13, 1776 Search PubMed; (b) C. Kim, J. Jeong, M. Vellakkaran and S. Hong, ACS Catal., 2022, 12, 13225–13233 Search PubMed; (c) C. Kim, Y. Kim and S. Hong, Nat. Commun., 2024, 15, 5993 Search PubMed; (d) J. Kim, Y.-E. Kim and S. Hong, Angew. Chem., Int. Ed., 2024, 63, e202409561 Search PubMed.
  13. K. Kwon, R. T. Simons, M. Nandakumar and J. L. Roizen, Chem. Rev., 2022, 122, 2353–2428 Search PubMed.
  14. (a) Y. Jiang, D. Liu, M. E. Rotella, G. Deng, Z. Liu, W. Chen, H. Zhang, M. C. Kozlowski, P. J. Walsh and X. Yang, J. Am. Chem. Soc., 2023, 145, 16045–16057 Search PubMed; (b) Y. Jiang, H. Li, H. Tang, Q. Zhang, H. Yang, Y. Pan, C. Zou, H. Zhang, P. J. Walsh and X. Yang, Chem. Sci., 2025, 16, 962–969 Search PubMed.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.